Owens & Minor (NYSE:OMI) Reaches New 52-Week Low - Should You Sell?

Owens & Minor, Inc. (NYSE:OMI - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $8.39 and last traded at $8.51, with a volume of 137753 shares traded. The stock had previously closed at $8.65.

Analyst Ratings Changes

Several brokerages recently commented on OMI. Robert W. Baird cut their price target on shares of Owens & Minor from $15.00 to $14.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 4th. UBS Group cut their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a research report on Thursday. Citigroup dropped their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating for the company in a research report on Tuesday, November 5th. Finally, Barclays decreased their target price on shares of Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a research note on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat.com, Owens & Minor presently has an average rating of "Hold" and an average price target of $16.79.

Owens & Minor Stock Performance

The firm has a 50 day moving average of $12.93 and a 200-day moving average of $13.91. The stock has a market capitalization of $593.28 million, a PE ratio of -11.84, a P/E/G ratio of 0.25 and a beta of 0.48. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09.

Insider Buying and Selling

In other news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the transaction, the chief financial officer now owns 130,822 shares of the company's stock, valued at approximately $1,546,316.04. This represents a 3.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 3.59% of the company's stock.

Institutional Trading of Owens & Minor

Hedge funds have recently added to or reduced their stakes in the business. Inspire Advisors LLC lifted its position in shares of Owens & Minor by 11.2% in the 4th quarter. Inspire Advisors LLC now owns 15,350 shares of the company's stock worth $201,000 after acquiring an additional 1,548 shares during the period. Blue Trust Inc. grew its stake in shares of Owens & Minor by 57.4% during the fourth quarter. Blue Trust Inc. now owns 4,387 shares of the company's stock worth $57,000 after purchasing an additional 1,600 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in Owens & Minor by 4.9% during the second quarter. The Manufacturers Life Insurance Company now owns 36,366 shares of the company's stock worth $491,000 after acquiring an additional 1,709 shares in the last quarter. Sterling Capital Management LLC lifted its holdings in Owens & Minor by 758.3% during the fourth quarter. Sterling Capital Management LLC now owns 2,060 shares of the company's stock worth $27,000 after acquiring an additional 1,820 shares in the last quarter. Finally, Legal & General Group Plc lifted its holdings in shares of Owens & Minor by 0.9% in the fourth quarter. Legal & General Group Plc now owns 212,061 shares of the company's stock valued at $2,772,000 after purchasing an additional 1,991 shares in the last quarter. Institutional investors own 98.04% of the company's stock.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.